- Gadoteridol
Drugbox
IUPAC_name = gadolinium(+3) cation; 2- [4-(2-hydroxypropyl)-7,10-bis(2-oxido-2-oxoethyl)-1,4,7,10-tetrazacyclododec-1-yl] acetate
width = 150
CAS_number = 120066-54-8
CAS_supplemental =
ATC_prefix = V08
ATC_suffix = CA04
ATC_supplemental =
PubChem = 60714
DrugBank =
chemical_formula =
C=17 | H=29 | Gd=1 | N=4 | O=7
molecular_weight = 558.68 g/mol
smiles = CC(CN1CCN(CCN(CCN(CC1)CC(=O) [O-] )CC(=O) [O-] )CC(=O) [O-] )O. [Gd+3]
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
licence_US =
legal_AU =
legal_CA =
legal_UK =
legal_US = Rx-only
legal_status =
routes_of_administration = IVGadoteridol (INN) is a magnetic resonance contrast agent, used particularly in the imaging of the
central nervous system . It is sold under the brand name ProHance.References
*cite web | url = http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=6094 | title = Gadoteridol (ProHance) prescribing information (revised May 2007) | author = Bracco Diagnostic Inc. | month = May | year = 2007 | accessdate = 2008-07-13 | publisher = U.S.
National Library of Medicine | work = DailyMed
Wikimedia Foundation. 2010.